Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19

Detalles Bibliográficos
Autores principales: Rhoads, Daniel D., Cherian, Sree S., Roman, Katharine, Stempak, Lisa M., Schmotzer, Christine L., Sadri, Navid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383529/
https://www.ncbi.nlm.nih.gov/pubmed/32303564
http://dx.doi.org/10.1128/JCM.00760-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383529/
https://www.ncbi.nlm.nih.gov/pubmed/32303564
http://dx.doi.org/10.1128/JCM.00760-20

Ejemplares similares